ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,671Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 49

$1.61M Total Retail Price of All Prescriptions

Rank: 1 out of 49

590 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 590 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

24% of this provider’s 590 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 17,252 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
LEVOTHYROXINE SODIUM 1,107 898 1 1
OMEPRAZOLE 870 662 2 4
SIMVASTATIN 852 626 3 2
POTASSIUM CHLORIDE 690 603 4 9
BUMETANIDE 604 519 5 42
HYDROCODONE-ACETAMINOPHEN 548 364 S3 6 7
GABAPENTIN 461 324 7 15
CRESTOR 440 354 8 23
AMLODIPINE BESYLATE 425 363 9 6
LISINOPRIL 397 288 10 3
METFORMIN HCL 326 243 11 10
ALLOPURINOL 294 246 12 21
DIGOXIN 287 260 13 39
VERAPAMIL ER 275 224 14 62
CITALOPRAM HBR 269 211 15 18
MELOXICAM 255 204 16 31
ZOLPIDEM TARTRATE 253 183 17 19
ZETIA 233 187 18 63
HYDROCHLOROTHIAZIDE 213 144 19 12
LOSARTAN-HYDROCHLOROTHIAZIDE 212 165 20 40
LOSARTAN POTASSIUM 210 183 21 14
WARFARIN SODIUM 200 195 22 8
ATENOLOL 192 142 23 17
CARVEDILOL 191 187 24 35
PREDNISONE 189 153 25 30
MIRTAZAPINE 188 118 26 53
METOPROLOL SUCCINATE 188 156 26 16
FUROSEMIDE 186 168 28 5
CYMBALTA 182 101 29 33
VYTORIN 177 170 30 86
SPIRIVA 170 123 31 37
OXYCODONE HCL 168 70 S2 32 80
FLECAINIDE ACETATE 163 163 33 104
METOLAZONE 154 131 34 90
NEXIUM 151 110 35 27
JANUVIA 147 102 36 44
DILTIAZEM ER 141 117 37 95
NATEGLINIDE 139 122 38 109
NAMENDA 136 121 39 41
FENTANYL 135 102 S2 40 59
FENOFIBRATE 133 118 41 96
AZITHROMYCIN 132 92 42 47
FLUOXETINE HCL 132 68 42 60
RAMIPRIL 128 119 44 79
SPIRONOLACTONE 128 95 44 26
CARBIDOPA-LEVODOPA 127 126 46 94
ADVAIR DISKUS 123 80 47 28
AMITRIPTYLINE HCL 121 59 R 48 56
LYRICA 119 60 49 83
NABUMETONE 115 111 50 117
ISOSORBIDE MONONITRATE ER 114 109 51 93
CELEBREX 109 74 52 57
PANTOPRAZOLE SODIUM 108 72 53 32
DILTIAZEM 24HR CD 108 105 53 65
INDAPAMIDE 108 77 53 75
SUCRALFATE 108 77 53 102
COMBIVENT 106 44 57 122
AMLODIPINE BESYLATE-BENAZEPRIL 105 90 58 123
SERTRALINE HCL 104 96 59 22
LEVOFLOXACIN 103 86 60 72
QUETIAPINE FUMARATE 103 35 60 71
CYCLOBENZAPRINE HCL 101 55 R 62 92
BYSTOLIC 99 79 63 61
TRICOR 98 87 64 125
ROPINIROLE HCL 98 98 64 66
PRADAXA 95 70 66 107
LANTUS 93 71 67 48
ATORVASTATIN CALCIUM 93 84 67 13
CLOPIDOGREL 92 84 69 46
EXELON 92 92 69 108
DIOVAN 92 74 69 49
TOPIRAMATE 91 20 72 130
TRIAMTERENE-HCTZ 91 91 72 43
CILOSTAZOL 90 84 74 131
BUPROPION HCL SR 89 51 75 134
PLAVIX 88 81 76 88
BISOPROLOL FUMARATE 86 79 77 135
PROPRANOLOL HCL 80 67 78 137
LAMOTRIGINE 80 24 78 137
DONEPEZIL HCL 77 70 80 24
DIOVAN HCT 76 68 81 76
METOCLOPRAMIDE HCL 75 73 82 98
NOVOLOG 74 57 83 115
VENLAFAXINE HCL ER 73 24 84 80
TRAZODONE HCL 72 52 85 54
GLIMEPIRIDE 68 68 86 49
DOXEPIN HCL 68 53 86 100
FELODIPINE ER 67 63 88 149
PRAMIPEXOLE DIHYDROCHLORIDE 65 65 89 113
TAMSULOSIN HCL 64 58 90 25
LEVEMIR 63 57 91 153
CIPROFLOXACIN HCL 62 52 92 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 47 93 34
ACTOS 60 43 93 155
FLUTICASONE PROPIONATE 60 48 93 51
PHENYTOIN SODIUM EXTENDED 59 45 96 116
DEXILANT 57 54 97 67
NIASPAN 56 49 98 104
SINGULAIR 55 22 99 70
PRAVASTATIN SODIUM 55 48 99 20
TRAMADOL HCL-ACETAMINOPHEN 55 45 99 160
OXYCODONE-ACETAMINOPHEN 54 31 S2 102 111
SYNTHROID 53 53 103 45
TRAMADOL HCL 52 31 104 29
LEVOXYL 52 47 104 164
SYMBICORT 51 34 106 68
KLOR-CON 10 51 39 106 117
AMPHETAMINE SALT COMBO 51 19 S2 106 169
RANITIDINE HCL 50 28 109 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.